(1S,2R,3S,4R,5S,6S)-2,3,4,5,6-Pentahydroxycyclohexyl 2-amino-4-{[carboxy(imino)methyl]amino}-2,3,4,6-tetradeoxy-alpha-D-arabino-hexopyranoside hydrochloride (1:1)

Basic Information

View in Editor

CAS Number

19408-46-9

Molecular Formula

C14H26ClN3O9

Molecular Weight

415.83 g/mol

Chemical Classification

Basic Chemical Raw Materials Organic Chemicals Carboxylic Acids

Basic Chemical Raw Materials Organic Chemicals Ethers

Basic Chemical Raw Materials Organic Chemicals Amines

Basic Chemical Raw Materials Organic Chemicals Heterocyclic Compounds

Pharmaceutical Chemicals Pharmaceutical Intermediates Heterocyclic Intermediates

Fine Chemicals Surfactants Anionic Surfactants

Laboratory Chemicals Research Chemicals Biochemical Reagents

Basic Physical Properties

Physical State

No data available

Melting Point

No data available

Boiling Point

No data available

Density

1.9700

Flash Point

No data available

Solubility

H2O: soluble

Refractive Index

1.738

Vapor Pressure

No data available

SMILES

View in Editor

CC1C(CC(C(O1)OC2C(C(C(C(C2O)O)O)O)O)N)N=C(C(=O)O)N.Cl

InChI

InChI=1S/C14H25N3O9.ClH/c1-3-5(17-12(16)13(23)24)2-4(15)14(25-3)26-11-9(21)7(19)6(18)8(20)10(11)22;/h3-11,14,18-22H,2,15H2,1H3,(H2,16,17)(H,23,24);1H/t3-,4+,5+,6-,7+,8+,9-,10+,11+,14-;/m1./s1

InChIKey

ZDRBJJNXJOSCLR-NZXABURVSA-N

LogP

-3.906229999999995

Topological Polar Surface Area

218.81 Å²

Hydrogen Bond Donor/Acceptor

10 / 12

Complexity

532

Synonyms & References

English

CAS-19408-46-9
2-amino-2-[(2R,3S,5S,6R)-5-amino-2-methyl-6-[(2S,3S,5S,6R)-2,3,4,5,6-pentahydroxycyclohexyl]oxyoxan-3-yl]iminoacetic acid;hydrochloride
Kasumin
SXA18D440T
MFCD00058459
SR-05000001429
6980-18-3
Kasugamycin hydrochloride, VETRANAL(TM), analytical standard
Kasugamycin hydrochloride, Antibiotic for Culture Media Use Only
AS-13793
Kasugamycin (hydrochloride)
HMS1923C17
19408-46-9
AKOS037515814
SPECTRUM1505038
UNII-SXA18D440T
NCGC00164389-01
Q-201265
Kasugamycin hydrochloride
D-chiro-Inositol, 3-O-[2-amino-4-[(carboxyiminomethyl)amino]-2,3,4,6-tetradeoxy-?-D-arabino-hexopyranosyl]-, monohydrochloride (9CI); Kasugamycin, monohydrochloride (8CI); Kasugamycin hydrochloride; Kasumin
PD087170
CS-0013931
CCG-214366
D-CHIRO-INOSITOL, 3-O-(2-AMINO-4-((CARBOXYIMINOMETHYL)AMINO)-2,3,4,6-TETRADEOXY-.ALPHA.-D-ARABINO-HEXOPYRANOSYL)-, HYDROCHLORIDE (1:1)
CHEMBL3186853
Kasugamycin hydrochloride from Streptomyces kasugaensis, >=90% (HPLC)
Tox21_302236
Q27289442
D-chiro-Inositol, 3-O-(2-amino-4-((carboxyiminomethyl)amino)-2,3,4,6-tetradeoxy-alpha-D-arabino-hexopyranosyl)-, monohydrochloride
SR-05000001429-2
NCGC00255614-01

MDL Number

MFCD00058459

FAQ

What regulatory guidelines apply to (1S,2R,3S,4R,5S,6S)-2,3,4,5,6-Pentahydroxycyclohexyl 2-amino-4-{[carboxy(imino)methyl]amino}-2,3,4,6-tetradeoxy-alpha-D-arabino-hexopyranoside hydrochloride (1:1) (CAS: 19408-46-9)?

This compound falls under the classification of organic chemicals and is subject to various regulatory guidelines such as REACH in Europe, which requires registration and evaluation of substances, as well as GHS (Globally Harmonized System of Classification and Labeling of Chemicals) for hazard communication. In the USA, it is regulated by the EPA and FDA for safety and environmental concerns, including potential impacts on aquatic ecosystems and human health.

Are there alternatives to (1S,2R,3S,4R,5S,6S)-2,3,4,5,6-Pentahydroxycyclohexyl 2-amino-4-{[carboxy(imino)methyl]amino}-2,3,4,6-tetradeoxy-alpha-D-arabino-hexopyranoside hydrochloride (1:1) (CAS: 19408-46-9) in synthesis?

In synthesis, there are several alternatives to this compound, such as using isomers or analogs like (1R,2S,3R,4S,5R,6R)-2,3,4,5,6-pentahydroxycyclohexyl 2-amino-4-{[carboxy(imino)methyl]amino}-2,3,4,6-tetradeoxy-alpha-D-arabino-hexopyranoside. Common alternative reagents include various amino acids and sugar derivatives, which can be used to synthesize similar structures with slight modifications.

What is the market or research trend for (1S,2R,3S,4R,5S,6S)-2,3,4,5,6-Pentahydroxycyclohexyl 2-amino-4-{[carboxy(imino)methyl]amino}-2,3,4,6-tetradeoxy-alpha-D-arabino-hexopyranoside hydrochloride (1:1) (CAS: 19408-46-9)?

The market for this compound shows a gradual increase in research interest, particularly in its applications in pharmaceuticals and biotechnology. Recent trends indicate a growing focus on developing new drugs and therapeutic agents, with a particular emphasis on natural product derivatives. The compound's unique structure makes it a promising candidate for further exploration in these fields.

How should waste containing (1S,2R,3S,4R,5S,6S)-2,3,4,5,6-Pentahydroxycyclohexyl 2-amino-4-{[carboxy(imino)methyl]amino}-2,3,4,6-tetradeoxy-alpha-D-arabino-hexopyranoside hydrochloride (1:1) (CAS: 19408-46-9) be handled?

Waste containing this compound should be carefully managed to ensure environmental safety. Collection should be done in appropriate containers and transported to a licensed hazardous waste facility for incineration or professional waste disposal. It is crucial to follow local and national regulations for hazardous waste disposal, including proper labeling and documentation. Additionally, wearing protective gear such as gloves and safety goggles during handling is recommended to prevent exposure.